Treosulfan Unknown Status Phase 2 Trials for Diffuse Large Cell Lymphoma / Chronic Myeloid Leukemia (CML) / Myelodysplastic Syndrome / Multiple Myeloma (MM) / Chronic Lymphocytic Leukaemia (CLL) / Lymphoma, Hodgkins / Leukemias Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00598624Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)